GITR
3 abstracts
Abstract
Transforming growth factor-b1 and soluble co-inhibitory immune checkpoints as putative drivers of immune suppression in advanced basal cell carcinoma.Org: University of Pretoria, Steve Biko Academic Hospital, The Medical Oncology Centre of Rosebank,
Abstract
Dysregulation of immune checkpoint proteins in patients with newly diagnosed early breast cancer undergoing neoadjuvant chemotherapy: A comparison between patients with triple negative breast cancer (TNBC) and non-TNBC.Org: The Medical Oncology Centre of Rosebank, Johannesburg, South Africa, Department of Immunology, Faculty of Health Science, University of Pretoria, Pretoria, South Africa, University of Pretoria, Department of Immunology, Pretoria, South Africa, Netcare, City of Johannesburg, South Africa, Drs Gritzman and Thatcher Inc. Pathology Laboratory, City of Johannesburg, South Africa,
Abstract
Implications of GITR expression profile for precision immunotherapeutics.Org: Moores Cancer Center, UC San Diego Health, Medical College of Wisconsin and WIN Consortium, Dartmouth Cancer Center, Lebanon, NH, OmniSeq (Labcorp), OmniSeq Inc. (Labcorp),